Belgium· BE-AMP-SAM664045-00
Wainzua 45 mg
A eplontersen product containing eplontersen sodium, registered in Belgium by AstraZeneca. The same ATC class is registered in 13 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Eplontersen is registered in 13 of 19 countries.
Countries holding a registration under ATC N07XX21 (eplontersen), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Eplontersen · ATC N07XX21
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Eplontersen Sodium
- Manufacturer
- AstraZeneca
- Country
- Belgium (BE)
- ATC code
- N07XX21
- ATC class
- Eplontersen
- Defined daily dose
- 1.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb4921359
- be_apb7749344
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eplontersen in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaWAINZUAAstraZeneca AB, Södertälje
- IcelandWainzuaAstraZeneca AB*
- NorwayWainzuaAstraZeneca AB
- SwedenWainzua 45 mg Injektionsvätska, lösning i förfylld injektionspennaAstraZeneca AB
- IrelandWainzua 45 mg solution for injection in pre-filled penAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Wainzua
- Liechtenstein · Wainzua
- Norway · Wainzua
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/827f46e1-76ea-4083-8b9d-892ff19ae1e9 GET /v1/drugs/827f46e1-76ea-4083-8b9d-892ff19ae1e9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled pen",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Wainzua 45 mg",
"name_fr": "Wainzua 45 mg",
"name_nl": "Wainzua 45 mg",
"amp_code": "SAM664045-00",
"strengths": [
"56.0000",
"56.0000"
],
"pack_count": 1,
"substances": [
"Eplontersen Sodium",
"Eplontersen",
"Disodium Hydrogen Phosphate Anhydrous",
"Sodium Dihydrogen Phosphate Dihydrate",
"Sodium Chloride",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Eplontersen",
"authorisation_numbers": [
"EU/1/24/1875/001"
]
}See everything about eplontersen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.